| 000 | 00917nam a2200253 a 4500 | ||
|---|---|---|---|
| 001 | vtls000071154 | ||
| 003 | KUKTEM | ||
| 005 | 20251125095344.0 | ||
| 008 | 130607t2012 njua g bi 001 0 eng d | ||
| 020 | _a9780470587195 | ||
| 039 | 9 |
_a201312111418 _bsafura _y201306071621 _zirma |
|
| 040 | _aUMP | ||
| 090 | _aRM301.42 .T44 2012 | ||
| 245 | 0 | 0 |
_aTherapeutic targets : _bmodulation, inhibition, and activation / _cedited by Luis M. Botana, Mabel Loza |
| 260 |
_aHoboken, N.J. : _bJohn Wiley & Sons, _c2012 |
||
| 300 |
_axii, 482 p. : _bill. , ; _c25cm. |
||
| 504 | _aIncludes bibliographical references and index | ||
| 650 | 0 | _aDrug Discovery | |
| 650 | 0 |
_aDrug Industry _xorganization & administration |
|
| 650 | 0 | _aPublic-Private Sector Partnerships | |
| 700 | 1 | _aBotana, Luis M. | |
| 700 | 1 | _aLoza, Mabel. | |
| 999 |
_aVIRTUA40 _c70584 _d70590 |
||
| 999 | _aVTLSSORT0080*0200*0400*0900*2450*2600*3000*5040*6500*6501*6502*7000*7001*9992 | ||